HCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow HCA
HCA Healthcare, Inc. (HCA) EV/Sales
As of 16 October 2026, HCA Healthcare, Inc. (HCA) trades at a EV/Sales of 1.9×. Over the past ten years it has ranged from 1.1× (March 2020) to 2.3× (March 2026); the current reading is higher than 86% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.1× | 22.58% |
| FY2024 | 1.7× | (3.88%) |
| FY2023 | 1.7× | (2.25%) |
| FY2022 | 1.8× | (9.51%) |
| FY2021 | 2.0× | 20.12% |
| FY2020 | 1.6× | 1.18% |
| FY2019 | 1.6× | 0.54% |
| FY2018 | 1.6× | 9.00% |
| FY2017 | 1.5× | 3.90% |
| FY2016 | 1.4× | (1.83%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.7× | (13.74%) |
| Mar 2026 | 2.0× | (2.90%) |
| Dec 2025 | 2.1× | 7.37% |
| Sep 2025 | 1.9× | 3.24% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.8× |
| UHS Universal Health Services, Inc. compare | 0.9× |
| PACS PACS Group, Inc. compare | 1.4× |
| THC Tenet Healthcare Corporation compare | 1.5× |
| DVA DaVita Inc. compare | 1.6× |
| ENSG The Ensign Group, Inc. compare | 1.8× |
| HCA HCA Healthcare, Inc. | 1.9× |
| EHC Encompass Health Corporation compare | 2.4× |
| CHE Chemed Corporation compare | 2.6× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on HCA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement